Literature DB >> 33339893

Comment on "Heterogeneity in PD-L1 expression in malignant peritoneal mesothelioma with systemic or intraperitoneal chemotherapy".

Haitang Yang1, Sean R R Hall2, Beibei Sun3, Feng Yao4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33339893      PMCID： PMC7961042          DOI： 10.1038/s41416-020-01214-8

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  3 in total

1.  Dihydroartemisinin ameliorates chronic nonbacterial prostatitis and epithelial cellular inflammation by blocking the E2F7/HIF1α pathway.

Authors:  Yan Zhou; Jun-Hao Wang; Jian-Peng Han; Jian-Yong Feng; Kuo Guo; Fei Du; Wen-Bin Chen; Yong-Zhang Li
Journal:  Inflamm Res       Date:  2022-03-13       Impact factor: 4.575

Review 2.  Biomarkers for Malignant Pleural Mesothelioma-A Novel View on Inflammation.

Authors:  Melanie Vogl; Anna Rosenmayr; Tomas Bohanes; Axel Scheed; Milos Brndiar; Elisabeth Stubenberger; Bahil Ghanim
Journal:  Cancers (Basel)       Date:  2021-02-06       Impact factor: 6.639

3.  NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural Mesothelioma.

Authors:  Haitang Yang; Sean R R Hall; Beibei Sun; Liang Zhao; Yanyun Gao; Ralph A Schmid; Swee T Tan; Ren-Wang Peng; Feng Yao
Journal:  Cancers (Basel)       Date:  2021-03-29       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.